TrialAntimicrobial agents and chemotherapy2015

Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trials.

C M Rubino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.